Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|6|669-674

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.6, 2006-06, pp. : 669-674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CC-Chemokine Receptors in Chronic Obstructive Pulmonary Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 2, 2007-06 ,pp. : 75-79

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

By  

Current Pharmaceutical Design, Vol. 11, Iss. 16, 2005-06 ,pp. : 2053-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines and Chemokine Receptors Blockers as New Drugs for the Treatment of Chronic Obstructive Pulmonary Disease

By  

Current Medicinal Chemistry, Vol. 20, Iss. 35, 2013-11 ,pp. : 4317-4349

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease (COPD) may represent a serious threat

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ghrelin is promising for chronic obstructive pulmonary disease (COPD)-associated cachexia

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite